公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA取消

61 记录

产品持有公司班级有效性
Bordetella pertussis (IgG)10338930124EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
Bordetella pertussis (IgM)10338930129EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
Bordetella pertussis IgA10338930327EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII06/01/2035
Borrelia + VlsE IgG81148560021EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII17/03/2035
Borrelia IgM81148560024EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII17/03/2035
Chikungunya IgG81148560003EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII22/06/2035
Chikungunya IgM81148560002EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII22/06/2035
Dengue NS181148560001EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII22/06/2035
Dengue virus (IgG)10338930125EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/10/2034
EUROArray HLA-DQ2/DQ8 Direto81148560071EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII09/07/2028
EUROArray HLA-DQ2/DQ8-h Direto81148560072EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII09/07/2028
EUROArray HPV81148560043EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/03/2027
EUROLINE Paraneoplastic Neurologic Syndromes 12 Ag (IgG)10338930322EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/08/2034
Hepatite E (HEV) IgG81148560028EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII26/09/2036
IF: Leishmania donovani IgG81148560064EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/09/2027
IF: Leishmania donovani IgM81148560065EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/09/2027
IF: Schistosoma mansoni IgG81148560025EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII29/08/2036
IF: Schistosoma mansoni IgM81148560026EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII29/08/2036
Mycoplasma pneumoniae IgA81148560039EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/12/2036
Mycoplasma pneumoniae IgG81148560040EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/12/2036
Mycoplasma pneumoniae IgM81148560032EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII10/10/2036
Parvovírus B19 IgG10338930160EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/01/2035
Parvovírus B19 IgM10338930161EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII19/01/2035
Rubéola Avidez IgG10338930109EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034
Rubéola IgG10338930107EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/08/2034

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家